“Design And Development Of A Novel Formulation Of Pacritinib For Treatment Of Adults Intermediate And High Risk Myelofibrosis With Low Platelet Count”. Journal of Pharmaceutical Negative Results, Jan. 2023, pp. 649-52, https://doi.org/10.47750/pnr.2023.14.S01.84.